HB8656, titled the Ballistic Armor Made in America Act of 2026, would require the Department of Justice to prioritize domestic sourcing for ballistic-resistant body armor. The bill directs the National Institute of Justice to require manufacturers and other entities in its compliance testing program to disclose the countries where the armor and its ballistic fibers are manufactured, grown, reprocessed, reused, recycled, or produced. That information would then be added to the NIJ compliant products list, and products using foreign-origin ballistic fibers would be barred from using “Made in America” markings or similar language.
The bill also adds a new domestic sourcing restriction to DOJ procurement law. The Attorney General would be prohibited from using DOJ funds to buy ballistic-resistant body armor containing ballistic fibers produced outside the United States, unless domestic products are unavailable when needed at U.S. market prices or the fibers meet existing Berry Amendment and Kissel Amendment compliance standards. The bill further requires the Federal Law Enforcement Training Centers to provide training to state and local entities that receive DOJ grants to buy body armor, focusing on the new disclosure requirements. It also defines ballistic-resistant body armor, hard armor, soft armor, and the compliant products list, and allows the NIJ to extend the disclosure rules to future advanced materials that replace ballistic fibers.
Impact
If enacted, the bill would amend title 28 of the U.S. Code by creating a new domestic sourcing requirement for DOJ procurement of ballistic-resistant body armor and by expanding NIJ disclosure and publication obligations. It would affect manufacturers, suppliers, and entities seeking NIJ certification, as well as state and local governments that purchase armor with DOJ grant funds. The measure would also constrain the Department of Justice’s purchasing options and could shift demand toward U.S.-based ballistic fiber production and domestic armor manufacturers.
Sentiment
Based on the bill text and its introduction, the measure appears to reflect a pro-domestic-manufacturing and procurement-security posture, with sponsors emphasizing American sourcing and transparency. There is no recorded committee debate or vote history in the provided material, so no formal opposition or bipartisan support can be identified from the available record. The bill was referred to the House Judiciary Committee and had not advanced further in the provided status information.
Contention
The main points of potential contention are the domestic sourcing mandate and the disclosure/public labeling requirements. Supporters are likely to favor the bill for strengthening U.S. manufacturing and supply-chain transparency, while critics may argue it could raise costs, limit procurement flexibility, or complicate timely acquisition of protective equipment. Another possible issue is the exception language, which allows noncompliant procurement when domestic products are unavailable at U.S. market prices or when fibers meet Berry Amendment and Kissel Amendment standards; that balance between domestic preference and operational need may be a focal point for debate. No specific objections or amendments are recorded in the provided transcripts.